How Thyroid Disorders Affect Anemia
Both hypothyroidism and hyperthyroidism significantly increase the risk of anemia, with overt hypothyroidism showing the strongest association (84% increased odds), and correction of thyroid dysfunction improves hemoglobin levels.
Mechanisms of Thyroid-Related Anemia
Thyroid hormones directly influence erythropoiesis through multiple pathways:
- Direct stimulation of erythrocyte precursor proliferation
- Enhanced erythropoietin gene expression and production
- Iron metabolism alterations (particularly in hyperthyroidism)
- Oxidative stress in hyperthyroid states
- Bone marrow depression in hypothyroid states 1, 2
Clinical Evidence and Risk Quantification
The most robust evidence comes from a large pooled analysis of 42,162 participants 3, which demonstrated:
- Overt hypothyroidism: 84% increased odds of anemia (OR 1.84,95% CI 1.35-2.50)
- Subclinical hypothyroidism: 21% increased odds (OR 1.21,95% CI 1.02-1.43)
- Overt hyperthyroidism: 69% increased odds (OR 1.69,95% CI 1.00-2.87)
- Subclinical hyperthyroidism: 27% increased odds (OR 1.27,95% CI 1.03-1.57)
All thyroid dysfunction groups showed lower hemoglobin levels compared to euthyroid individuals 3.
Types of Anemia by Thyroid Status
Normocytic anemia is the predominant type (94% of cases), regardless of whether hypothyroidism or hyperthyroidism is present 4, 5. Macrocytic anemia occurs less frequently (6%), while microcytic anemia is rare unless concurrent iron deficiency exists 2.
In Hypothyroidism:
- Normocytic anemia from bone marrow suppression
- Decreased erythropoietin production
- Potential concurrent deficiencies (iron, B12, folate)
- Association with autoimmune conditions (pernicious anemia, celiac disease) 2
In Hyperthyroidism:
- Altered iron metabolism
- Oxidative stress-mediated erythrocyte damage
- Increased metabolic demands 2
Clinical Significance and Reversibility
A prospective study of 150 patients demonstrated that correction of thyroid dysfunction with levothyroxine (hypothyroidism) or carbimazole (hyperthyroidism) resulted in significant hemoglobin improvement at 3 months 1. This confirms the causal relationship and therapeutic relevance.
However, an important caveat: subclinical thyroid dysfunction does not appear to be an independent risk factor for developing new-onset anemia during follow-up 6. The EPIC-Norfolk cohort showed no significant change in hemoglobin over 4.7 years in subclinical disease (adjusted HR 0.99 for subclinical hypothyroidism, 0.52 for subclinical hyperthyroidism) 6.
Screening Recommendations
Screen for thyroid dysfunction in anemic patients only after excluding the three most common causes: chronic kidney disease, inflammation, and iron deficiency 4. In the EPIC-Norfolk study, when these three conditions were excluded, the prevalence of anemia in euthyroid individuals was 4.7%, compared to 14.6% in overt hyperthyroidism and 7.7% in overt hypothyroidism 4.
Practical Algorithm:
- First-line anemia workup: Complete blood count, iron studies, inflammatory markers, renal function
- If unexplained normocytic anemia persists: Measure TSH
- If TSH abnormal: Measure free T4 to classify as subclinical vs. overt dysfunction 7
- In autoimmune thyroid disease: Consider anti-thyroid peroxidase and anti-thyroglobulin antibodies, as these predict progression to overt dysfunction 8, 9, 10
Bidirectional Relationship
Iron deficiency itself negatively impacts thyroid hormone status 11. Meta-analysis shows that patients with iron deficiency have significantly lower TSH (MD: -0.24 mIU/L), FT4 (MD: -1.18 pmol/L), and FT3 (MD: -0.22 pmol/L) levels, with positive correlation between serum ferritin and thyroid hormone levels 11. This creates a potential vicious cycle requiring simultaneous management of both conditions.
Management Implications
Routine complete blood count monitoring should be performed in all patients with thyroid disorders, particularly those with overt dysfunction 1, 5. Conversely, patients with treatment-resistant or refractory anemia warrant thyroid function assessment 2.
The correction of overt thyroid dysfunction improves anemia without requiring specific anemia treatment in many cases 1. However, concurrent deficiencies (iron, B12, folate) must be identified and treated simultaneously, especially in autoimmune thyroid disease where multiple autoimmune conditions may coexist 2.
Common Pitfall:
Do not attribute anemia solely to thyroid dysfunction without excluding other causes. The association is real but thyroid disease is rarely the sole etiology—concurrent iron deficiency, autoimmune gastritis, celiac disease, or chronic inflammation frequently contribute 2, 4.